81_FR_91099 81 FR 90858 - National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting

81 FR 90858 - National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 241 (December 15, 2016)

Page Range90858-90858
FR Document2016-30075

Federal Register, Volume 81 Issue 241 (Thursday, December 15, 2016)
[Federal Register Volume 81, Number 241 (Thursday, December 15, 2016)]
[Notices]
[Page 90858]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-30075]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Biomedical Imaging and Bioengineering; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel.
    Date: February 23, 2017.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, Suite 
920, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Manana Sukhareva, Ph.D., Scientific Review 
Officer, National Institute of Biomedical Imaging and 
Bioengineering, National Institutes of Health, 6707 Democracy 
Boulevard, Suite 959, Bethesda, MD 20892, (301) 451-3397, 
[email protected].

    Dated: December 8, 2016.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-30075 Filed 12-14-16; 8:45 am]
BILLING CODE 4140-01-P



                                               90858                     Federal Register / Vol. 81, No. 241 / Thursday, December 15, 2016 / Notices

                                                 Dated: December 12, 2016.                             hereby given of a meeting of the                      DEPARTMENT OF HEALTH AND
                                               Leslie Kux,                                             National Advisory Council for                         HUMAN SERVICES
                                               Associate Commissioner for Policy.                      Biomedical Imaging and Bioengineering.
                                               [FR Doc. 2016–30113 Filed 12–14–16; 8:45 am]               The meeting will be open to the                    National Institutes of Health
                                               BILLING CODE 4164–01–P                                  public as indicated below, with                       Center for Scientific Review; Notice of
                                                                                                       attendance limited to space available.                Closed Meeting
                                                                                                       Individuals who plan to attend and
                                               DEPARTMENT OF HEALTH AND                                need special assistance, such as sign                   Pursuant to section 10(d) of the
                                               HUMAN SERVICES                                          language interpretation or other                      Federal Advisory Committee Act, as
                                                                                                       reasonable accommodations, should                     amended (5 U.S.C. App.), notice is
                                               National Institutes of Health                           notify the Contact Person listed below                hereby given of the following meeting.
                                                                                                       in advance of the meeting.                              The meeting will be closed to the
                                               National Institute of Biomedical                                                                              public in accordance with the
                                               Imaging and Bioengineering; Notice of                      The meeting will be closed to the
                                                                                                                                                             provisions set forth in sections
                                               Closed Meeting                                          public in accordance with the
                                                                                                                                                             552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                                                                       provisions set forth in sections
                                                 Pursuant to section 10(d) of the                                                                            as amended. The grant applications and
                                                                                                       552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                               Federal Advisory Committee Act, as                                                                            the discussions could disclose
                                                                                                       as amended. The grant applications
                                               amended (5 U.S.C. App.), notice is                                                                            confidential trade secrets or commercial
                                                                                                       and/or contract proposals and the
                                               hereby given of the following meeting.                                                                        property such as patentable material,
                                                                                                       discussions could disclose confidential
                                                 The meeting will be closed to the                                                                           and personal information concerning
                                                                                                       trade secrets or commercial property
                                               public in accordance with the                                                                                 individuals associated with the grant
                                                                                                       such as patentable material, and
                                               provisions set forth in sections                                                                              applications, the disclosure of which
                                                                                                       personal information concerning
                                               552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,                                                                    would constitute a clearly unwarranted
                                                                                                       individuals associated with the grant
                                               as amended. The grant applications and                                                                        invasion of personal privacy.
                                                                                                       applications and/or contract proposals,
                                               the discussions could disclose                                                                                  Name of Committee: Center for Scientific
                                                                                                       the disclosure of which would
                                               confidential trade secrets or commercial                                                                      Review, Special Emphasis Panel;
                                                                                                       constitute a clearly unwarranted
                                               property such as patentable material,                                                                         Applications in Biobehavioral Regulation,
                                                                                                       invasion of personal privacy.                         Learning, and Ethology.
                                               and personal information concerning
                                               individuals associated with the grant                     Name of Committee: National Advisory                  Date: December 21, 2016.
                                               applications, the disclosure of which                   Council for Biomedical Imaging and                      Time: 11:00 a.m. to 12:00 p.m.
                                                                                                       Bioengineering.                                         Agenda: To review and evaluate grant
                                               would constitute a clearly unwarranted                                                                        applications.
                                               invasion of personal privacy.                             Date: January 24, 2017.
                                                                                                         Open: 8:30 a.m. to 12:00 p.m.                         Place: National Institutes of Health, 6701
                                                 Name of Committee: National Institute of                Agenda: Report from the Institute Director,         Rockledge Drive, Bethesda, MD 20892
                                               Biomedical Imaging and Bioengineering                   other Institute Staff and scientific                  (Telephone Conference Call).
                                               Special Emphasis Panel.                                                                                         Contact Person: Andrea B Kelly, Ph.D.,
                                                                                                       presentation.
                                                 Date: February 23, 2017.                                                                                    Scientific Review Officer, Center for
                                                                                                         Place: The William F. Bolger Center,
                                                 Time: 11:00 a.m. to 4:00 p.m.                                                                               Scientific Review, National Institutes of
                                                                                                       Franklin Building, Classroom 15/16, 9600              Health, 6701 Rockledge Drive, Room 3182,
                                                 Agenda: To review and evaluate grant
                                                                                                       Newbridge Drive, Potomac, MD 20854.                   MSC 7770, Bethesda, MD 20892, (301) 455–
                                               applications.
                                                                                                         Closed: 1:30 p.m. to 3:30 p.m.                      1761, kellya2@csr.nih.gov.
                                                 Place: National Institutes of Health, Two
                                                                                                         Agenda: To review and evaluate grant
                                               Democracy Plaza, Suite 920, 6707 Democracy                                                                      This notice is being published less than 15
                                               Boulevard, Bethesda, MD 20892 (Virtual                  applications and/or proposals.                        days prior to the meeting due to the timing
                                               Meeting).                                                 Place: The William F. Bolger Center,                limitations imposed by the review and
                                                 Contact Person: Manana Sukhareva, Ph.D.,              Franklin Building, Classroom 15/16, 9600              funding cycle.
                                               Scientific Review Officer, National Institute           Newbridge Drive, Potomac, MD 20854.
                                                                                                                                                             (Catalogue of Federal Domestic Assistance
                                               of Biomedical Imaging and Bioengineering,                  Contact Person: David T. George, Ph.D.,            Program Nos. 93.306, Comparative Medicine;
                                               National Institutes of Health, 6707                     Acting Associate Director, Office of Research         93.333, Clinical Research, 93.306, 93.333,
                                               Democracy Boulevard, Suite 959, Bethesda,               Administration, National Institute of                 93.337, 93.393–93.396, 93.837–93.844,
                                               MD 20892, (301) 451–3397, sukharem@                     Biomedical Imaging and Bioengineering,                93.846–93.878, 93.892, 93.893, National
                                               mail.nih.gov.                                           6707 Democracy Boulevard, Room 920,                   Institutes of Health, HHS)
                                                                                                       Bethesda, MD 20892.
                                                 Dated: December 8, 2016.                                                                                      Dated: December 8, 2016.
                                                                                                          Any interested person may file written
                                               David Clary,                                            comments with the committee by forwarding             Michelle Trout,
                                               Program Analyst, Office of Federal Advisory             the statement to the Contact Person listed on         Program Analyst, Office of Federal Advisory
                                               Committee Policy.                                       this notice. The statement should include the         Committee Policy.
                                               [FR Doc. 2016–30075 Filed 12–14–16; 8:45 am]            name, address, telephone number and when              [FR Doc. 2016–30072 Filed 12–14–16; 8:45 am]
                                               BILLING CODE 4140–01–P                                  applicable, the business or professional              BILLING CODE 4140–01–P
                                                                                                       affiliation of the interested person.
                                                                                                          Information is also available on the
                                               DEPARTMENT OF HEALTH AND                                Institute’s/Center’s home page: http://               DEPARTMENT OF HEALTH AND
                                               HUMAN SERVICES                                          www.nibib1.nih.gov/about/NACBIB/                      HUMAN SERVICES
                                                                                                       NACBIB.htm, where an agenda and any
                                               National Institutes of Health                           additional information for the meeting will           National Institutes of Health
                                                                                                       be posted when available.
rmajette on DSK2TPTVN1PROD with NOTICES




                                               National Institute of Biomedical                          Dated: December 8, 2016.                            National Human Genome Research
                                               Imaging and Bioengineering; Notice of                   David Clary,                                          Institute; Notice of Closed Meeting
                                               Meeting                                                 Program Analyst, Office of Federal Advisory             Pursuant to section 10(d) of the
                                                 Pursuant to section 10(d) of the                      Committee Policy.                                     Federal Advisory Committee Act, as
                                               Federal Advisory Committee Act, as                      [FR Doc. 2016–30074 Filed 12–14–16; 8:45 am]          amended (5 U.S.C. App.), notice is
                                               amended (5 U.S.C. App.), notice is                      BILLING CODE 4140–01–P                                hereby given of the following meeting.


                                          VerDate Sep<11>2014   15:19 Dec 14, 2016   Jkt 241001   PO 00000   Frm 00087   Fmt 4703   Sfmt 4703   E:\FR\FM\15DEN1.SGM   15DEN1



Document Created: 2016-12-15 01:11:03
Document Modified: 2016-12-15 01:11:03
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesFebruary 23, 2017.
FR Citation81 FR 90858 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR